Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Anesth Analg
2010 Feb 01;1102:455-60. doi: 10.1213/ANE.0b013e3181c5f689.
Show Gene links
Show Anatomy links
Inhibition of human alpha4beta2 neuronal nicotinic acetylcholine receptors by volatile aromatic anesthetics depends on drug hydrophobicity.
Solt K
,
Kelly EW
,
Cotten JF
,
Raines DE
.
???displayArticle.abstract???
Volatile aromatic compounds such as benzene are general anesthetics that cause amnesia, hypnosis, and immobility in response to noxious stimuli when inhaled. Although these compounds are not used clinically, they are frequently found in commercial items such as solvents and household cleaning products and are abused as inhalant drugs. Volatile aromatic anesthetics are useful pharmacological tools for probing the relationship between chemical structure and drug activity at putative general anesthetic targets. Neuronal nicotinic acetylcholine (nACh) receptors are ligand-gated ion channels widely expressed in the brain, which are thought to play important roles in learning and memory. In this study, we tested the hypothesis that aromatic anesthetics reversibly inhibit alpha(4)beta(2) neuronal nACh receptor function and sought to determine the structural correlates of receptor inhibition. Electrophysiological techniques were used to quantify the effects of 8 volatile aromatic anesthetics on currents elicited by 1 mM ACh and mediated by human alpha(4)beta(2) nACh receptors expressed in Xenopus oocytes. All of the volatile aromatic anesthetics used in this study reversibly inhibited alpha(4)beta(2) nACh receptors with IC(50) values ranging from 0.00091 atm for 1,2-difluorobenzene to 0.045 atm for hexafluorobenzene. With the exception of hexafluorobenzene, all of the compounds had IC(50) values less than minimum alveolar concentration. Inhibitory potency correlated poorly with the cation-pi binding energies of the compounds (r(2) = 0.48, P = 0.059). However, there was a good correlation between inhibitory potency and the octanol/gas partition coefficient (r(2) = 0.87, P = 0.0008). Volatile aromatic anesthetics potently and reversibly inhibit human alpha(4)beta(2) neuronal nACh receptors. This inhibition may play a role in producing amnesia. In contrast to N-methyl-d-aspartate receptors, the inhibitory potencies of aromatic anesthetics for alpha(4)beta(2) neuronal nACh receptors seem to be dependent on drug hydrophobicity rather than electrostatic properties. This implies that the volatile aromatic anesthetic binding site in the alpha(4)beta(2) neuronal nACh receptor is hydrophobic in character and differs from the nature of the binding site in N-methyl-D-aspartate receptors.
Alkondon,
The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex.
2004, Pubmed
Alkondon,
The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex.
2004,
Pubmed
Antognini,
Exaggerated anesthetic requirements in the preferentially anesthetized brain.
1993,
Pubmed
Antognini,
Hexafluorobenzene acts in the spinal cord, whereas o-difluorobenzene acts in both brain and spinal cord, to produce immobility.
2007,
Pubmed
Champtiaux,
Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.
2003,
Pubmed
Coates,
Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes.
2001,
Pubmed
,
Xenbase
Cordero-Erausquin,
Nicotinic receptor function: new perspectives from knockout mice.
2000,
Pubmed
Eger,
Acetylcholine receptors do not mediate the immobilization produced by inhaled anesthetics.
2002,
Pubmed
Fang,
Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis.
1996,
Pubmed
Flood,
Heteromeric nicotinic inhibition by isoflurane does not mediate MAC or loss of righting reflex.
2002,
Pubmed
Flood,
Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected.
1997,
Pubmed
,
Xenbase
Flood,
Neuronal nicotinic acetylcholine receptor modulation by general anesthetics.
1998,
Pubmed
Flores,
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
1992,
Pubmed
Franks,
Selective actions of volatile general anaesthetics at molecular and cellular levels.
1993,
Pubmed
Horishita,
The effects of volatile aromatic anesthetics on voltage-gated Na+ channels expressed in Xenopus oocytes.
2008,
Pubmed
,
Xenbase
Kelly,
Volatile aromatic anesthetics variably impact human gamma-aminobutyric acid type A receptor function.
2007,
Pubmed
,
Xenbase
Kenney,
Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.
2008,
Pubmed
Lendvai,
Nonsynaptic chemical transmission through nicotinic acetylcholine receptors.
2008,
Pubmed
Matsuura,
Inhibitory effects of isoflurane and nonimmobilizing halogenated compounds on neuronal nicotinic acetylcholine receptors.
2002,
Pubmed
Raines,
Nonhalogenated anesthetic alkanes and perhalogenated nonimmobilizing alkanes inhibit alpha(4)beta(2) neuronal nicotinic acetylcholine receptors.
2002,
Pubmed
,
Xenbase
Raines,
The N-methyl-D-aspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions.
2004,
Pubmed
,
Xenbase
Rampil,
Anesthetic potency (MAC) is independent of forebrain structures in the rat.
1993,
Pubmed
Rampil,
Anesthetic potency is not altered after hypothermic spinal cord transection in rats.
1994,
Pubmed
Smith,
The solubility of anesthetic gases in lipid bilayers.
1981,
Pubmed
Solt,
Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics.
2006,
Pubmed
,
Xenbase
Taheri,
What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs?
1991,
Pubmed
Tassonyi,
The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia.
2002,
Pubmed
Violet,
Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics.
1997,
Pubmed
,
Xenbase
Yamakura,
Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol.
2000,
Pubmed
,
Xenbase
Yamashita,
Isoflurane modulation of neuronal nicotinic acetylcholine receptors expressed in human embryonic kidney cells.
2005,
Pubmed